Results 261 to 270 of about 480,989 (325)

Oncolytic Probiotics with Molecular Pili for Solid Tumor Therapy

Advanced Science, EarlyView.
This study identifies Lactobacillus rhamnosus as an intrinsic oncolytic agent that triggers tumor metabolic collapse via calcium‐dependent ROS bursts. By chemically anchoring collagen‐targeting “molecular pili” to the bacterial surface, the engineered non‐transgenic probiotic (LR@MP) achieves targeted colonization and potent solid tumor suppression ...
Haodong Ge, Chengsheng Ding, Xiao Yang, Si Gao, Changjie Yang, Yuchen Hou, Hongye Wang, Linke Bian, Hao Zhong, Yifan Qu, Luyang Zhang, Junjun Ma, Zhengwei Cai, Wenguo Cui, Minhua Zheng   +14 more
wiley   +1 more source

Comment on: "Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study" by Busque et al. [PDF]

Blood Cancer J
Eşkazan AE.
europepmc   +1 more source

Economic implications of the different statin prescribing patterns in Central Portugal: a longitudinal analysis. [PDF]

J Pharm Policy Pract
Abrantes C, Negrão LG, Coelho C, Castel-Branco MM, Figueiredo IV, Fernandez-Llimos F.   +5 more
europepmc   +1 more source

Differentiation and Generic Sentences. [PDF]

Cogn Sci
Rothermund P, Deutsch R.
europepmc   +1 more source

The consequences of pharmaceutical tariffs in the United States. [PDF]

J Manag Care Spec Pharm
Sullivan SD, Grueger J, Sullivan AP, Ramsey SD.   +3 more
europepmc   +1 more source

Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era. [PDF]

J Clin Med
Favaloro EJ, Pasalic L, Lippi G.
europepmc   +1 more source

Prior Authorization, Quantity Limits, and Step Therapy for Patient-Administered Antiemetics.

JAMA Netw Open
Vu K, Gupta A, Chino F, Barnes J, Thom B, Kyle MA.   +5 more
europepmc   +1 more source